Converting Metoprolol Tartrate 25 mg Q8H to Metoprolol Succinate
A direct 1:1 total daily dose conversion is appropriate: switch from metoprolol tartrate 25 mg three times daily (75 mg total daily) to metoprolol succinate 75 mg once daily. 1
Conversion Rationale
The FDA-approved labeling for metoprolol succinate explicitly states: "when switching from immediate-release metoprolol to metoprolol succinate extended-release tablets, the same total daily dose of metoprolol succinate extended-release tablets should be used" 1. This applies to both hypertension and angina indications.
Your patient is currently taking:
- Metoprolol tartrate 25 mg Q8H = 75 mg total daily dose
- Convert to: Metoprolol succinate 75 mg once daily
Pharmacokinetic Support
Research demonstrates that metoprolol succinate and tartrate formulations produce similar hemodynamic and clinical effects despite different release profiles 2. The controlled-release succinate formulation achieves:
- Lower peak plasma concentrations but higher trough levels compared to immediate-release tartrate 3
- More consistent 24-hour beta-blockade with less fluctuation 3
- Equivalent total drug exposure (AUC) over the dosing interval 3
Studies in heart failure patients showed that switching from metoprolol tartrate 50 mg to metoprolol succinate CR/XL at equivalent total daily doses produced comparable efficacy and safety profiles 4.
Clinical Guidelines Context
Multiple cardiovascular guidelines reference metoprolol dosing but focus on target doses rather than conversion specifics:
- STEMI guidelines recommend initiating metoprolol tartrate 25-50 mg every 6-12 hours, then transitioning to once-daily metoprolol succinate over 2-3 days, titrating toward a target of 200 mg daily 5
- Heart failure guidelines recommend starting metoprolol succinate at 12.5-25 mg once daily and titrating to a target of 200 mg daily 6, 7
- Hypertension guidelines list metoprolol tartrate 100-200 mg twice daily or metoprolol succinate 50-200 mg once daily as equivalent options 8
Practical Implementation
Immediate switch approach:
- Stop metoprolol tartrate 25 mg Q8H
- Start metoprolol succinate 75 mg once daily the next morning
- No tapering or overlap period needed for this conversion
Monitoring after conversion:
- Check blood pressure and heart rate within 1-2 weeks
- Assess for signs of inadequate beta-blockade (tachycardia, hypertension) or excessive effect (bradycardia, hypotension)
- The extended-release formulation provides more stable drug levels, potentially reducing peak-related side effects
Important Caveats
Tablet splitting considerations: Metoprolol succinate tablets are scored and can be divided, but the whole or half tablet must be swallowed whole—never chewed or crushed 1. Since 75 mg is not a standard tablet strength, you may need to:
- Use a 100 mg tablet and split it (giving approximately 50 mg), accepting slight underdosing
- Use 50 mg once daily as the closest available dose
- Consider rounding up to 100 mg once daily if clinical indication supports higher dosing
Titration context: If this patient requires beta-blocker therapy for heart failure or post-MI, the current 75 mg daily dose is relatively low. Guidelines support titrating metoprolol succinate toward target doses of 200 mg daily for these indications 6, 7. The conversion represents an opportunity to reassess whether dose escalation is appropriate based on the underlying indication, tolerability, heart rate, and blood pressure response.